In this issue of Circulation is a provocative report by Morady and colleagues1 of the largest experience to date of attempts to ablate posteroseptal atrioventricular bypass tracts with a direct current catheter technique. At this juncture, 5 years after the first report of transvenous catheter ablation for this application, it seems appropriate to review the current status of this technique. The attractiveness of the transcatheter ablation technique is obvious. For the first time, the cardiologist may be able to provide more than palliative pharmacologic therapy, without the need to perform open heart surgery, to patients who have arrhythmias due to certain accessory pathways. However, before we rush ahead in advocating general clinical application of what is still an experimental technique, a number of questions must be addressed. The new therapy must be compared with established therapies, in this case surgical ablation of posteroseptal bypass tracts, with regard to efficacy, cost, applicability, and risks.
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In this issue of Circulation is a provocative report by Morady and colleagues1 of the largest experience to date of attempts to ablate posteroseptal atrioventricular bypass tracts with a direct current catheter technique. At this juncture, 5 years after the first report of transvenous catheter ablation for this application, it seems appropriate to review the current status of this technique. The attractiveness of the transcatheter ablation technique is obvious. For the first time, the cardiologist may be able to provide more than palliative pharmacologic therapy, without the need to perform open heart surgery, to patients who have arrhythmias due to certain accessory pathways. However, before we rush ahead in advocating general clinical application of what is still an experimental technique, a number of questions must be addressed. The new therapy must be compared with established therapies, in this case surgical ablation of posteroseptal bypass tracts, with regard to efficacy, cost, applicability, and risks.
A comparison of the catheter ablation technique with the current standard surgical procedure reveals that surgery is clearly more reliable at present than the catheter technique. Recent series suggest an efficacy approaching 100% with surgery for postero-septal2,3 bypass tracts compared with approximately 67% efficacy with the catheter technique in the study by Morady et a1l and other recent series. 4, 5 See p 1160 The disparity between success rates in patients in the present series with concealed bypass tracts compared with those with manifest Wolff-Parkinson-White syndrome is interesting but is as yet unexplained. Other investigators have not had uniform success in curing concealed bypass tracts with the catheter technique.4,5 The lower efficacy of a catheter technique has several potential explanations. First, we are probably still on the ascending limb of the "learning curve" with the catheter technique. We do not yet understand the mechanism by which this technique ablates bypass tracts. Perhaps the decreased efficacy with the present technique also relates in part to a failure to individualize location of the shock based on local ventriculoatrial conduction intervals. This limitation may be eliminated if methods for delivering the ablation energy that are not associated with barotrauma (such as radiofrequency energy) become available and prove efficacious in eliminating conduction over bypass tracts, which would allow more flexibility in the location for shock delivery.
A comparison of costs of the current standard surgical technique with the catheter technique should show obvious advantages of the catheter technique with regard to material, personnel time, hospitalization time, and recuperation time after hospital discharge with attendant loss of work or school time.
The applicability of the catheter ablation technique is clearly much more limited than the surgical technique. At this time, there is no bypass tract location that cannot be attacked surgically. The technique described in the report of Morady et a1l is clearly intended for a limited patient group with well circumscribed bypass tract locations (posteroseptal bypass tracts make up a minority of tracts that require therapy).
Finally, the relative risks of surgical ablation compared with catheter ablation of posteroseptal bypass tracts cannot be fully evaluated yet. Although the present series with over a 2-year follow-up goes a long way to establishing intermediate-term safety, long-term sequelae, such as stenosis of nearby coronary arteries due to the catheter ablation, cannot yet be fully eliminated because intimal hyperplasia has been observed in coronary arteries in close proximity to the sites of coronary sinus shocks in animal studies.6 However, the mortality and potential morbidity of the two procedures during the short-term does seem well established and is surprisingly comparable with each method in regard to disturbances of the normal conduction system and ablation-induced atrial tachyarrhythmias. More worrisome is the observation that late sudden death has followed catheter ablation of the atrioventric-ular junction and ventricular tachycardia foci. It cannot be denied, however, that the catheter technique is less invasive and associated with much less patient discomfort and a lack of a thoracotomy or sternotomy in most cases.
The methodology used in the study by Morady and colleagues' deserves close examination, for it departs in a number of ways from the usual practice. First, when catheter ablation has been performed to interrupt atrioventricular conduction through the normal conducting system, to cure ventricular tachycardia, and in previous reports of attempts to ablate bypass tracts, the operator determines the site at which the shock will be delivered based on the examination of appropriately timed intracardiac electrogram recordings. These recordings are usually monitored continuously from the site at which the shock delivery is planned until the last possible moment. In contrast, the technique used by Morady et all involved three steps: 1) determination that a posteroseptal bypass tract was present with the usual techniques of analyzing retrograde activation during ventricular pacing or supraventricular tachycardia with "earliest activation at the coronary sinus ostium"; 2) once it was determined that a posteroseptal bypass tract was present, the ostium of the coronary sinus was delineated angiographically; 3) after this step, the angiographic catheter was removed, and the catheter to be used for delivery of the ablation shock was inserted into the coronary sinus, and then positioned so that the electrodes through which the current would be delivered, were located at or outside the coronary sinus ostium. Thus, the investigators determined the shock location by anatomic landmarks. The prime reason for this is safety. By not delivering the shock within the coronary sinus, the chances of barotrauma-related complications should be minimized because the explosive force of the shock will be dissipated in the volume of the atria rather than in the coronary sinus. The use of an anatomic marker may result in decreased efficacy in ablating bypass tracts classified electrically as posteroseptal but located farther from the ostium. Catheters with 1-cm interelectrode distances were used in this study. This large interelectrode spacing really precludes precise pathway localization. For detailed mapping, a catheter with 1-2 mm spacing is necessary. Indeed, the findings in two patients in the present series who failed the attempted catheter ablation and later underwent open heart surgery suggest that this may be true. In addition, it is important to realize that there is a great deal of anatomic variation in bypass tracts classified electrically as posteroseptal. These pathways may follow an oblique course from left ventricle to right atrium through the pyramidal space, as well as following more direct routes. Thus, there is a range of anatomic locations that "posteroseptal"' pathways may occupy. However, the overall success rate of approximately two thirds in the present series is nearly identical to that reported by other investigators in smaller series of patients in whom shock delivery was guided by the intracardiac electrograms showing the shortest ventriculoatrial interval. On the other hand, the risk of perforation of the coronary sinus with the present technique does appear to be substantially less than that reported by other investigators who delivered shocks within the coronary sinus.4,7
The second facet in which the technique of Morady et al' differs from previously reported approaches is in the practice of connecting two electrodes together for shock delivery to increase the area over which the current is delivered, which decreases gas bubble formation and barotrauma. Whether or not barotrauma is necessary to effectively ablate cardiac tissue is not clear. Although barotrauma may not be necessary for ablation of ventricular tissue,8 this may not be true for ablation of posterior bypass tracts. In fact, the success of the technique used by Morady et all in which the shock is not delivered exactly at the bypass tract may indicate that barotrauma does play a role. In addition, the puzzling lack of dependence of efficacy on location of the anode (anterior or posterior chest) may also indicate a role of barotrauma. Thus, any means of potentially decreasing resultant barotrauma, such as making the intracardiac electrodes cathodic, and increasing surface area for delivery of shocks9 as did Morady et all may have varying effects on efficacy.
A third noteworthy aspect of the present technique is the emphasis on utilizing only unused 6 French electrode catheters. The one case in the present series in which coronary sinus rupture occurred, causing pericardial tamponade, involved a previously used catheter. It is not clear in this case whether breakdown of the dielectric strength resulted in delivery of electrical energy to the distal electrode causing perforation or whether movement of the catheter during the shock resulted in mechanical perforation. Bardy et a14 used larger 8.5 French electrode catheters to decrease the chance of dielectric breakdown. However, a higher incidence of coronary sinus perforation was noted with these catheters, and this incidence seemed to relate to an increased size of the catheter relative to the coronary sinus size. Thus, the trade-off of increased dielectric strength for a larger catheter size may be detrimental.
Investigators in previous studies of attempts at electrical ablation of posterior septal bypass tracts have performed coronary angiography to identify patients at risk of potential damage to coronary arteries; patients who had coronary arteries in close proximity to the coronary sinus were identified as high risk.4 Coronary angiography apparently was not performed before ablation in the present series. There were no apparent complications related to damage of coronary arteries, and coronary angiography performed in 10 patients late after the ablation did not reveal any obvious angiographic abnormality of the coronary arterial tree. Previous studies have shown that direct current shocks delivered within the coronary sinus may result in total obstruction of the coronary sinus (without apparent adverse functional effects),6 but this was not observed in any of the 24 patients who underwent late angiographic visualization of the coronary sinus in the series of Morady and colleagues.1
Based on these observations then, should the catheter ablation technique be recommended to anyone with a posteroseptal bypass tract that is involved in symptomatic tachyarrhythmias? I believe that if performed by an experienced operator, successful ablation is superior to long-term palliative pharmacologic therapy. Assuming that the bypass tract has been accurately localized, attempting ablation before surgery may ultimately prove reasonable. The question of whether a failed ablation attempt will increase the difficulty of subsequent surgery remains unanswered. Whether or not the risks and expense of this procedure in an attempt to simplify subsequent planned surgical ablation can be justified (as the authors put forth) in patients who have bypass tracts at other locations in addition to the posterior septum, I think is very questionable. In this case, the operator is placing the patient at risk for two procedures: ablation and surgery. Because the difficulty and morbidity of surgery in experienced centers is not increased by the presence of multiple bypass tracts, I would not consider this an indication for catheter ablation, but rather a contraindication.
The next question that arises is who should be doing this experimental procedure. I believe that at this early stage in its development with a relatively small number of patients worldwide exposed to the procedure, only centers that have experience in catheter ablation and that have an approved research protocol to examine methodology and to collect and report data should be performing this procedure. In this time of limited economic resources and increasing costs, it behooves us to collect systematically as much data as possible on new therapeutic modalities. It is only through complete and prospective collection of data, such as those presented in this report, that the true spectrum of benefits and risks will be brought to light at the earliest possible time.
Anyone performing this procedure should have immediate thoracic surgical backup in the event that perforation of the coronary sinus occurs, precipitating pericardial tamponade that cannot be controlled by needle aspiration (some groups perform the ablation itself in the operating room).4 '5 Finally, where should we focus further investigations? It seems obvious that attempts should be made to identify those patients in whom success is most likely and those in whom benefit is least likely from this procedure to spare patients unnecessary expense, discomfort, and time. This study failed to confirm the finding of Bardy et a14 that short (<80 msec) ventriculoatrial intervals were more likely to be associated with successful outcomes. However, this is not necessarily surprising because with the technique used by Morady et al,1 the shock delivery was not tailored to individual ventriculoatrial intervals. In addition, Morady et all excluded from their analysis four patients with the permanent form of junctional reciprocating tachycardia, in contrast to Bardy et a14 who did not exclude such patients. Further investigations are needed to ascertain the mechanism by which the procedure attains its ends. Is bypass tract tissue itself actually ablated, or as has been suggested by canine studies, is damage of the atrial tissue into which the bypass tract inserts more likely the mechanism by which ablation succeeds.10 One would hope that further studies on the effects of this procedure will shed light on the mechanisms by which some bypass tracts fail to conduct either antegradely or retrogradely. This information depends on precise, detailed methods to localize the accessory pathway. Finally, we should realize that this is an evolving technique, which is likely to undergo further modification as newer sources of ablative energies, such as radiofrequency and possibly lasers, are introduced.
